JU INSIGHT: Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients

By: Maximilian Pallauf, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria, Paracelsus Medical University Salzburg, University Hospital Salzburg, Austria; David D’Andrea, MD, PhD, Comprehensive Cancer Center, Medical University of Vienna, Austria; Frederik König, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria, University Medical Center Hamburg-Eppendorf, Germany; Ekaterina Laukhtina, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria; Takafumi Yanagisawa, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria, The Jikei University School of Medicine, Tokyo, Japan; Morgan Rouprêt, MD, PhD, AP-HP, Pitié-Salpêtriére Hospital, Sorbonne University, Paris, France; Siamak Daneshmand, MD, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles; Hooman Djaladat, MD, MS, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles; Alireza Ghoreifi, MD, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles; Francesco Soria, MD, San Giovanni Battista Hospital, University of Studies of Torino, Italy; Kazutoshi Fujita, MD, PhD, Kindai University Faculty of Medicine, Osaka, Japan; Stephen A. Boorjian, MD, Mayo Clinic, Rochester, Minnesota; Aaron M. Potretzke, MD, PhD, Mayo Clinic, Rochester, Minnesota; Andrea Mari, MD, University of Florence, Careggi Hospital, Italy; Mathieu Roumiguié, MD, CHU Institut Universitaire du Cancer de Toulouse, France; Alessandro Antonelli, MD, PhD, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Italy; Alberto Bianchi, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Italy; Zine-Eddine Khene, MD, University of Rennes, France; John P. Sfakianos, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, New York; Marcus Jamil, MD, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Joost L. Boormans, MD, PhD, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands; Jay D. Raman, MD, Penn State Health, Hershey, Pennsylvania; Nico C. Grossmann, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria, University Hospital Zurich, Switzerland, Luzerner Kantonsspital, Lucerne, Switzerland; Alberto Breda, MD, PhD, Fundació Puigvert, Autonomous University of Barcelona, Spain; Axel Heidenreich, MD, PhD, Comprehensive Cancer Center, Medical University of Vienna, Austria, University Hospital Cologne, Germany; Francesco Del Giudice, MD, “Sapienza” University of Rome, Policlinico Umberto I Hospital, Italy; Nirmish Singla, MD, The James Buchanan Brady Urological Institute, The Johns Hopkins, University School of Medicine, Baltimore, Maryland; Shahrokh F. Shariat, MD, Comprehensive Cancer Center, Medical University of Vienna, Austria, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Jordan, Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria, Weill Cornell Medical College, New York, New York, University of Texas Southwestern, Dallas, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Benjamin Pradere, MD, MSc, Comprehensive Cancer Center, Medical University of Vienna, Austria, La Croix du Sud Hospital, Quint-Fonsegrives, France | Posted on: 17 Mar 2023